Connect Biopharma Holdings (CNTB) Prepaid Assets (2020 - 2026)
Connect Biopharma Holdings (CNTB) posted Prepaid Assets of $9.0 million for Q1 2026, up 36.69% sequentially from $6.6 million in Q4 2025, and up 139.5% YoY from $3.8 million in Q1 2025.
Connect Biopharma Holdings (CNTB) Prepaid Assets (2020 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Prepaid Assets for 7 years, with the latest figure at $9.0 million in Q1 2026.
- Quarterly Prepaid Assets rose 139.5% year-over-year to $9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.0 million (up 139.5% YoY) and the FY2025 annual result came in at $6.6 million, up 166.8% from the prior year.
- Prepaid Assets improved to $9.0 million in Q1 2026 per CNTB's latest filing, from $6.6 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $9.0 million in Q1 2026 and troughed at $2.2 million in Q2 2024.
- A 5-year average of $4.7 million and a median of $4.2 million in 2023 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets slumped 54.0% in 2022, then soared 176.84% in 2025.
- Over 5 years, Prepaid Assets stood at $2.7 million in 2022, then jumped by 60.18% to $4.2 million in 2023, then sank by 42.02% to $2.5 million in 2024, then jumped by 166.8% to $6.6 million in 2025, then surged by 36.69% to $9.0 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $9.0 million, $6.6 million, and $7.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Connect Biopharma Holdings | 148.41 Mn | 148.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.20 Mn |
| Mar 31, 2026 | 8.99 Mn |
| Dec 31, 2025 | 6.57 Mn |
| Sep 30, 2025 | 7.80 Mn |
| Jun 30, 2025 | 5.99 Mn |
| Mar 31, 2025 | 3.75 Mn |
| Dec 31, 2024 | 2.46 Mn |
| Jun 30, 2024 | 2.16 Mn |
| Dec 31, 2023 | 4.25 Mn |
| Jun 30, 2023 | 2.36 Mn |
| Dec 31, 2022 | 2.65 Mn |
| Jun 30, 2022 | 4.60 Mn |
| Dec 31, 2021 | 5.77 Mn |
| Dec 31, 2020 | 4.23 Mn |